Pupillary Involvement in Miller Fisher Syndrome

REFERENCES

• Fisher CM. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med 1956;255:57–65
   PubMed Web of Science ®Google Scholar
• Chiba A, Kusunoki S, Shimizu T, Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol 1992;31:677–679
   PubMed Web of Science ®Google Scholar
• Willison HJ, Veitch J, Paterson G, Kennedy PG. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J Neurol Neurosurg Psychiatry 1993;56:204–206
   PubMed Web of Science ®Google Scholar
• Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology 1993;43:1911–1917
   PubMed Web of Science ®Google Scholar
• Yuki N. Acute paresis of extraocular muscles associated with IgG anti-GQ1b antibody. Ann Neurol 1996;39:668–672
   PubMed Web of Science ®Google Scholar
• Yuki N, Sato S, Tsuji S, Hozumi I, Miyatake T. An immunologic abnormality common to Bickerstaff's brain stem encephalitis and Fisher’s syndrome. Neurol Sci 1993;118:83–87
   Google Scholar
• Berlit P, Rakicky J. The Miller Fisher syndrome. Review of the literature. J Clin Neuroophthalmol 1992;12:57–63
   PubMedGoogle Scholar
• Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T. Clinical features and prognosis of Miller Fisher syndrome. Neurology 2001;56:1104–1106
   PubMed Web of Science ®Google Scholar
• al-Din SN, Anderson M, Eeg-Olofsson O, Trontelj JV. Neuro-ophthalmic manifestations of the syndrome of ophthalmoplegia, ataxia and areflexia: a review. Acta Neurol Scand 1994;89:157–163
   PubMedGoogle Scholar
• Odaka M, Yuki N, Hirata K. Anti-GQ1b IgG antibody syndrome: clinical and immunological range. J Neurol Neurosurg Psychiatry 2001;70:50–55
   PubMed Web of Science ®Google Scholar
• Yuki N, Sato S, Tsuji S, Ohsawa T, Miyatake T. Frequent presence of anti-GQ1b antibody in Fisher’s syndrome. Neurology 1993;43:414–417
   PubMed Web of Science ®Google Scholar
• Yuki N, Odaka M, Hirata K. Acute ophthalmoparesis (without ataxia) associated with anti-GQ1b IgG antibody: clinical features. Ophthalmology 2001;108:196–200
   PubMed Web of Science ®Google Scholar
• Lee SH, Lim GH, Kim JS, Oh SY, Kim JK, Cha JK, Yun CH, Kang JK, Lee H, Song HK. Chung KC. Acute ophthalmoplegia (without ataxia) associated with anti-GQ1b antibody. Neurology 2008;71:426–429
   PubMed Web of Science ®Google Scholar
• Bae JS, Kim JK, Kim SH, Kim OK. Bilateral internal ophthalmoplegia as an initial sole manifestation of Miller Fisher syndrome. J Clin Neurosci 2009;16:963–964
   PubMedGoogle Scholar
• Radziwill AJ, Steck AJ, Borruat FX, Bogousslavsky J. Isolated internal ophthalmoplegia associated with IgG anti-GQ1b antibody. Neurology 1998;50:307
   PubMedGoogle Scholar
• Chan YC, Wilder-Smith E, Chee MW. Acute ophthalmoplegia with pupillary areflexia associated with anti-GQ1b antibody. J Clin Neurosci 2004;11:658–660
   PubMedGoogle Scholar
• Fleury V, Aqallal A, Lagrange E, Besson G, Caudie C. Acute bilateral mydriasis associated with anti-GQ1b antibody. J Clin Neurosci 2010;17:514–515
   PubMedGoogle Scholar
• Bulder MM, van Gijn J. The man in black with headache, photophobia and fixed pupils. Pract Neurol 2011;11:231–233
   PubMedGoogle Scholar
• Okajima T, Imamura S, Kawasaki S, Ideta T, Tokuomi H. Fisher’s syndrome: a pharmacological study of the pupils. Ann Neurol 1977;2:63–65
   PubMedGoogle Scholar
• Keane JR. Tonic pupils with acute ophthalmoplegic polyneuritis. Ann Neurol 1977;2:393–396
   PubMedGoogle Scholar
• Najim al-Din AS, Anderson M, Eeg-Olofsson O, Trontelj JV. Neuro-ophthalmic manifestations of the syndrome of ophthalmoplegia, ataxia and areflexia. Observations on 20 patients. Acta Neurol Scand 1994;89:87–94
   PubMedGoogle Scholar
• Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T. Clinical features and prognosis of Miller Fisher syndrome. Neurology 2001;56:1104–1106
   PubMed Web of Science ®Google Scholar
• Ito M, Kuwabara S, Odaka M, Misawa S, Koga M, Hirata K, Yuki N. Bickerstaff’s brainstem encephalitis and Fisher syndrome form a continuous spectrum: clinical analysis of 581 cases. J Neurol 2008;255:674–682
   PubMed Web of Science ®Google Scholar
• Keane JR. Bilateral ocular paralysis: analysis of 31 patients. Arch Neurol 2007;64:178–180
   PubMedGoogle Scholar
• Nitta T, Kase M, Shinmei Y, Yoshida K, Chin S, Ohno S. Mydriasis with light-near dissociation in Fisher’s syndrome. Jpn J Ophthalmol 2007;51:224–227
   PubMedGoogle Scholar
• Mori M, Kuwabara S, Yuki N. Fisher syndrome: clinical features, immunopathogenesis and management. Expert Rev Neurother 2012;12:39–51
   PubMed Web of Science ®Google Scholar
• Kusunoki S. Diagnosis, pathogenesis and treatment of Miller Fisher syndrome and related disorders: clinical significance of antiGQ1b IgG antibody. Expert Rev Neurother 2003;1:133–140
   Google Scholar
• Roberts M, Willison H, Vincent A, Newsom-Davis J. Serum factor in Miller Fisher variant of Guillain-Barré syndrome and neurotransmitter release. Lancet 1994;343:454–455
   PubMed Web of Science ®Google Scholar
• Plomp JJ, Molenaar PC, O’Hanlon GM, Jacobs BC, Veitch J, Daha MR, van Doorn PA, van der Meché FG, Vincent A, Morgan BP, Willison HJ. Miller Fisher antiGQ1b antibodies: α-latrotoxin-like effects on motor end plates. Ann Neurol 1999;45:189–199
   PubMed Web of Science ®Google Scholar
• Kuwabara S, Asahina M, Nakajima M, Mori M, Fukutake T, Hattori T, Yuki N. Special sensory ataxia in Miller Fisher syndrome detected by postural body sway analysis. Ann Neurol 1999;45:533–536
   PubMed Web of Science ®Google Scholar
• Willison HJ, O’Hanlon GM, Paterson G, Veitch J, Wilson G, Roberts M, Tang T, Vincent A. A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18. J Clin Invest 1996;97:1155–1164
   PubMed Web of Science ®Google Scholar
• Kusunoki S, Chiba A, Kanazawa I. Anti-GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia. Muscle Nerve 1999;8:1071–1074
   Google Scholar
• Inoue A, Koh C, Iwahashi T. Detection of serum anticerebellar antibodies in patients with Miller Fisher syndrome. Eur Neurol 1999;42:230–234
   PubMedGoogle Scholar
• Tüzün E, Kürtüncü M, Lang B, Içöz S, Akman-Demir G, Eraksoy M, Vincent A. Bickerstaff's encephalitis and Miller Fisher syndrome associated with voltage-gated potassium channel and novel anti-neuronal antibodies. Eur J Neurol 2010;17:1304–1307
   PubMed Web of Science ®Google Scholar
• Jehle T, Puvanachandra N. Ophthalmoplegie mit beidseitiger Mydriasis. Ophthalmologe 2012;109:76–78
   PubMedGoogle Scholar
• Kawasaki A. Anisoci oria. Continuum Lifelong Learning Neurol 2009;15:218–235
   Google Scholar
• Snyder LA, Rismondo V, Miller NR. The Fisher variant of Guillain-Barré syndrome (Fisher syndrome). J Neuroophthalmol 2009;29:312–324
   PubMedGoogle Scholar
• Caccavale A, Mignemi L. Acute onset of a bilateral areflexical mydriasis in Miller-Fisher syndrome: a rare neuro-ophthalmologic disease. J Neuroophthalmol 2000;20:61–62
   PubMedGoogle Scholar
• Mori M, Kuwabara S, Fukutake T, Hattori T. Intravenous immunoglobulin therapy for Miller Fisher syndrome. Neurology 2007;68:1144–1146
   PubMed Web of Science ®Google Scholar
• Papanikolaou T, Gray C, Boothman B, Naylor G, Mariatos G. Acute bilateral ophthalmoparesis with pupillary areflexical mydriasis in Miller-Fisher syndrome treated with intravenous immunoglobulin. J Ophthalmol 2010;2010: Article ID: 291840
   PubMedGoogle Scholar